These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Comparison of SPIO and USPIO for in vitro labeling of human monocytes: MR detection and cell function. Oude Engberink RD, van der Pol SM, Döpp EA, de Vries HE, Blezer EL. Radiology; 2007 May; 243(2):467-74. PubMed ID: 17456871 [Abstract] [Full Text] [Related]
5. [Labeling of mesenchymal stem cells with different superparamagnetic particles of iron oxide and detectability with MRI at 3T]. Ittrich H, Lange C, Dahnke H, Zander AR, Adam G, Nolte-Ernsting C. Rofo; 2005 Aug; 177(8):1151-63. PubMed ID: 16021549 [Abstract] [Full Text] [Related]
6. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: mechanisms and comparison of ferumoxides and ferumoxtran-10. Raynal I, Prigent P, Peyramaure S, Najid A, Rebuzzi C, Corot C. Invest Radiol; 2004 Jan; 39(1):56-63. PubMed ID: 14701989 [Abstract] [Full Text] [Related]
7. T1 and T2 relaxivity of intracellular and extracellular USPIO at 1.5T and 3T clinical MR scanning. Simon GH, Bauer J, Saborovski O, Fu Y, Corot C, Wendland MF, Daldrup-Link HE. Eur Radiol; 2006 Mar; 16(3):738-45. PubMed ID: 16308692 [Abstract] [Full Text] [Related]
9. Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model XXX. Daldrup-Link HE, Rudelius M, Oostendorp RA, Jacobs VR, Simon GH, Gooding C, Rummeny EJ. Acad Radiol; 2005 Apr; 12(4):502-10. PubMed ID: 15831425 [Abstract] [Full Text] [Related]
14. Visualization of antigen-specific human cytotoxic T lymphocytes labeled with superparamagnetic iron-oxide particles. Beer AJ, Holzapfel K, Neudorfer J, Piontek G, Settles M, Krönig H, Peschel C, Schlegel J, Rummeny EJ, Bernhard H. Eur Radiol; 2008 Jun; 18(6):1087-95. PubMed ID: 18286290 [Abstract] [Full Text] [Related]
15. Detection of viability of transplanted beta cells labeled with a novel contrast agent - polyvinylpyrrolidone-coated superparamagnetic iron oxide nanoparticles by magnetic resonance imaging. Zhang B, Jiang B, Chen Y, Huang H, Xie Q, Kang M, Zhang H, Zhai C, Wu Y. Contrast Media Mol Imaging; 2012 Jun; 7(1):35-44. PubMed ID: 22344878 [Abstract] [Full Text] [Related]
16. Cell tagging with clinically approved iron oxides: feasibility and effect of lipofection, particle size, and surface coating on labeling efficiency. Matuszewski L, Persigehl T, Wall A, Schwindt W, Tombach B, Fobker M, Poremba C, Ebert W, Heindel W, Bremer C. Radiology; 2005 Apr; 235(1):155-61. PubMed ID: 15749976 [Abstract] [Full Text] [Related]
17. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: implications for cellular magnetic resonance imaging. Arbab AS, Wilson LB, Ashari P, Jordan EK, Lewis BK, Frank JA. NMR Biomed; 2005 Oct; 18(6):383-9. PubMed ID: 16013087 [Abstract] [Full Text] [Related]
19. In vivo fate of superparamagnetic iron oxides during sepsis. Fujii H, Yoshikawa K, Berliner LJ. Magn Reson Imaging; 2002 Apr; 20(3):271-6. PubMed ID: 12117609 [Abstract] [Full Text] [Related]